Valirx eyes partnerships as first VAL201 study hits the markShares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of Share XValirx eyes partnerships as first VAL201 study hits the markhttps://pharmaphorum.com/news/valirx-eyes-partnerships-as-first-val201-study-hits-the-mark/
